ARTICLES BY THIS AUTHOR

• 12/29/2020

  Saskatchewan to release plan for rollout of Moderna vaccine for northern residents

• 12/29/2020

  Zeposia: new oral treatment for relapsing-remitting multiple sclerosis

  Third oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada.
• 12/29/2020

  U.K. okays 'vaccine for the world'; extends time between doses

• 12/29/2020

  Windsor, Ont., hospital postpones elective surgeries after Jan. 4 due to COVID surge

• 12/28/2020

  All COVID-19 vaccine clinics in Ontario set to reopen today after holiday closures

• 12/28/2020

  Favipiravir oral tablets being considered by Health Canada as a COVID-19 treatment

  Third drug to be filed for treatment of COVID-19 under Interim Order, following IV remdesivir and IV bamlanivimab.
• 12/28/2020

  Ontario government facing criticism after COVID 19 shots slowed over holidays

• 12/23/2020

  P.E.I. launching mental health and addictions app

• 12/23/2020

  Health Canada authorizes Moderna's COVID-19 vaccine ahead of holidays

• 12/22/2020

  New prescription hypnotic for insomnia now available in Canada

  First marketed orexin receptor antagonist is approved for adults with difficulties in falling asleep and/or maintaining sleep.